Hence, the ability of Rab25 to increase OPG expression in a subset of cancer cell lines and to increase OPG release by the majority of cancer cell lines assessed, suggests that amplification of Rab25 may provide survival advantages for cancer cell independent of TRAIL and RANKL. Here, TNFRSF11B is linked to cancer.